Anika Therapeutics, Inc. Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends
Anika Therapeutics, Inc. (ANIK) reported Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends of 54.12 thousand shares for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends · last filed 2013-03-14
- Anika Therapeutics, Inc. incremental common shares attributable to dilutive effect of nonvested shares with forfeitable dividends for fiscal 2012 was 54.12K shares, a 8.57% decline from fiscal 2011.
- Anika Therapeutics, Inc. incremental common shares attributable to dilutive effect of nonvested shares with forfeitable dividends for fiscal 2011 was 59.20K shares, a 186.94% increase from fiscal 2010.
- Anika Therapeutics, Inc. incremental common shares attributable to dilutive effect of nonvested shares with forfeitable dividends for fiscal 2010 was 20.63K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends 12 month |
|---|---|
| 2012-12-31 | 54.12K shares 10-K · filed 2013-03-14 |
| 2011-12-31 | 59.20K shares 10-K · filed 2013-03-14 |
| 2010-12-31 | 20.63K shares 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |